<?xml version="1.0" ?><!DOCTYPE PubmedArticleSet PUBLIC "-//NLM//DTD PubMedArticle, 1st June 2018//EN" "https://dtd.nlm.nih.gov/ncbi/pubmed/out/pubmed_180601.dtd"><PubmedArticleSet><PubmedArticle>    <MedlineCitation Status="In-Data-Review" Owner="NLM">        <PMID Version="1">30315187</PMID>        <DateRevised>            <Year>2018</Year>            <Month>11</Month>            <Day>14</Day>        </DateRevised>        <Article PubModel="Electronic">            <Journal>                <ISSN IssnType="Electronic">2045-2322</ISSN>                <JournalIssue CitedMedium="Internet">                    <Volume>8</Volume>                    <Issue>1</Issue>                    <PubDate>                        <Year>2018</Year>                        <Month>Oct</Month>                        <Day>12</Day>                    </PubDate>                </JournalIssue>                <Title>Scientific reports</Title>                <ISOAbbreviation>Sci Rep</ISOAbbreviation>            </Journal>            <ArticleTitle>Cytopathological Study of the Circulating Tumor Cells filtered from the Cancer Patients' Blood using Hydrogel-based Cell Block Formation.</ArticleTitle>            <Pagination>                <MedlinePgn>15218</MedlinePgn>            </Pagination>            <ELocationID EIdType="doi" ValidYN="Y">10.1038/s41598-018-33464-1</ELocationID>            <Abstract>                <AbstractText>Circulating tumor cells have emerged as biomarkers for estimating the tumor burden and metastatic potential of cancer patients. However, to date, most of studies and applications of circulating tumor cells have been conducted and applied to epithelial cancers such as breast, colorectal, and prostate tumor. The only FDA-cleared method, CellSearch, makes use of antibody against epithelial surface protein expressed on CTCs, thus obstructing wide application for various cancers with non-epithelial and semi-epithelial characteristics including renal cell carcinoma. Due to rarity and ambiguity of CTCs, designed experiment including non-biased CTC isolation and subsequent cytopathological study for finding applicable immunomarkers are urgently needed for clinical use of CTCs for less-studied cancers. Here, in order to construct the fundamental step for CTC diagnosis without limitation of its epithelial characteristics, we present the simple and novel method which incorporate both label-free CTC isolation and pathological study using hydrogel-based cell block formation. Six cell lines from lung, ovarian, kidney cancers were used to make cell block and analyzed by conventional immunocytochemical staining method to find the candidate markers for CTC. Especially for renal cancer, the physically isolated CTCs were further immunocytochemically examined with the screened candidate markers by cell block construction, and verified their clinical utility using blood samples from patients with renal cell carcinoma. This comprehensive study demonstrates that the present approach can be used to find the potential markers for any type of cancers regardless of their epithelial characteristics and isolate the specific type of CTCs in label-free manners.</AbstractText>            </Abstract>            <AuthorList CompleteYN="Y">                <Author ValidYN="Y">                    <LastName>Kang</LastName>                    <ForeName>Yoon-Tae</ForeName>                    <Initials>YT</Initials>                    <Identifier Source="ORCID">http://orcid.org/0000-0003-1596-7815</Identifier>                    <AffiliationInfo>                        <Affiliation>Cell Bench Research Center, Korea Advanced Institute of Science and Technology, 291 Daehak-ro, Yuseong-gu, Daejeon, 34141, Republic of Korea. kyoontae@umich.edu.</Affiliation>                    </AffiliationInfo>                    <AffiliationInfo>                        <Affiliation>College of Engineering, University of Michigan, 2800 Plymouth Road, Ann Arbor, 48109-2800, United States. kyoontae@umich.edu.</Affiliation>                    </AffiliationInfo>                </Author>                <Author ValidYN="Y">                    <LastName>Kim</LastName>                    <ForeName>Young Jun</ForeName>                    <Initials>YJ</Initials>                    <Identifier Source="ORCID">http://orcid.org/0000-0001-7274-8411</Identifier>                    <AffiliationInfo>                        <Affiliation>Cell Bench Research Center, Korea Advanced Institute of Science and Technology, 291 Daehak-ro, Yuseong-gu, Daejeon, 34141, Republic of Korea.</Affiliation>                    </AffiliationInfo>                    <AffiliationInfo>                        <Affiliation>Department of Nanoengineering, University of California, San Diego, La Jolla, California, 92093, United States.</Affiliation>                    </AffiliationInfo>                </Author>                <Author ValidYN="Y">                    <LastName>Lee</LastName>                    <ForeName>Tae Hee</ForeName>                    <Initials>TH</Initials>                    <AffiliationInfo>                        <Affiliation>Cell Bench Research Center, Korea Advanced Institute of Science and Technology, 291 Daehak-ro, Yuseong-gu, Daejeon, 34141, Republic of Korea.</Affiliation>                    </AffiliationInfo>                </Author>                <Author ValidYN="Y">                    <LastName>Cho</LastName>                    <ForeName>Young-Ho</ForeName>                    <Initials>YH</Initials>                    <Identifier Source="ORCID">http://orcid.org/0000-0002-0951-4388</Identifier>                    <AffiliationInfo>                        <Affiliation>Cell Bench Research Center, Korea Advanced Institute of Science and Technology, 291 Daehak-ro, Yuseong-gu, Daejeon, 34141, Republic of Korea. nanosys@kaist.ac.kr.</Affiliation>                    </AffiliationInfo>                </Author>                <Author ValidYN="Y">                    <LastName>Chang</LastName>                    <ForeName>Hee Jin</ForeName>                    <Initials>HJ</Initials>                    <Identifier Source="ORCID">http://orcid.org/0000-0003-2263-2247</Identifier>                    <AffiliationInfo>                        <Affiliation>Research Institute and Hospital, National Cancer Center, 323323 Ilsan-ro, Ilsandong-gu, Goyang-si Gyeonggi-do, 10408, Republic of Korea. heejincmd@ncc.re.kr.</Affiliation>                    </AffiliationInfo>                </Author>                <Author ValidYN="Y">                    <LastName>Lee</LastName>                    <ForeName>Hyun-Moo</ForeName>                    <Initials>HM</Initials>                    <AffiliationInfo>                        <Affiliation>Samsung Medical Center, 81 Irwon-ro, Gangnam-gu, Seoul, 06351, Republic of Korea.</Affiliation>                    </AffiliationInfo>                </Author>            </AuthorList>            <Language>eng</Language>            <GrantList CompleteYN="Y">                <Grant>                    <GrantID>10078295</GrantID>                    <Agency>Ministry of Trade, Industry and Energy (Ministry of Trade, Industry and Energy, Korea)</Agency>                    <Country/>                </Grant>                <Grant>                    <GrantID>NCC-1710880</GrantID>                    <Agency>National Cancer Center (NCC)</Agency>                    <Country/>                </Grant>            </GrantList>            <PublicationTypeList>                <PublicationType UI="D016428">Journal Article</PublicationType>            </PublicationTypeList>            <ArticleDate DateType="Electronic">                <Year>2018</Year>                <Month>10</Month>                <Day>12</Day>            </ArticleDate>        </Article>        <MedlineJournalInfo>            <Country>England</Country>            <MedlineTA>Sci Rep</MedlineTA>            <NlmUniqueID>101563288</NlmUniqueID>            <ISSNLinking>2045-2322</ISSNLinking>        </MedlineJournalInfo>        <CommentsCorrectionsList>            <CommentsCorrections RefType="Cites">                <RefSource>Biosens Bioelectron. 2014 Jan 15;51:213-8</RefSource>                <PMID Version="1">23962709</PMID>            </CommentsCorrections>            <CommentsCorrections RefType="Cites">                <RefSource>Sci Rep. 2016 Feb 29;6:22076</RefSource>                <PMID Version="1">26924553</PMID>            </CommentsCorrections>            <CommentsCorrections RefType="Cites">                <RefSource>Theranostics. 2017 Jul 22;7(13):3179-3191</RefSource>                <PMID Version="1">28900503</PMID>            </CommentsCorrections>            <CommentsCorrections RefType="Cites">                <RefSource>Adv Mater. 2013 Apr 24;25(16):2368-73</RefSource>                <PMID Version="1">23495071</PMID>            </CommentsCorrections>            <CommentsCorrections RefType="Cites">                <RefSource>Biotechnol Bioeng. 1988 Apr 20;31(6):607-12</RefSource>                <PMID Version="1">18584651</PMID>            </CommentsCorrections>            <CommentsCorrections RefType="Cites">                <RefSource>J Cell Sci. 2008 Mar 1;121(Pt 5):664-74</RefSource>                <PMID Version="1">18270270</PMID>            </CommentsCorrections>            <CommentsCorrections RefType="Cites">                <RefSource>J Clin Oncol. 2009 May 1;27(13):2177-84</RefSource>                <PMID Version="1">19332733</PMID>            </CommentsCorrections>            <CommentsCorrections RefType="Cites">                <RefSource>Cancer Res Treat. 2016 Oct;48(4):1229-1242</RefSource>                <PMID Version="1">27034142</PMID>            </CommentsCorrections>            <CommentsCorrections RefType="Cites">                <RefSource>PLoS One. 2016 Apr 21;11(4):e0153018</RefSource>                <PMID Version="1">27101285</PMID>            </CommentsCorrections>            <CommentsCorrections RefType="Cites">                <RefSource>Br J Cancer. 2011 Sep 6;105(6):847-53</RefSource>                <PMID Version="1">21829190</PMID>            </CommentsCorrections>            <CommentsCorrections RefType="Cites">                <RefSource>Cancer Cytopathol. 2015 Dec;123(12):696-706</RefSource>                <PMID Version="1">26671736</PMID>            </CommentsCorrections>            <CommentsCorrections RefType="Cites">                <RefSource>Br J Cancer. 2012 Oct 9;107(8):1286-94</RefSource>                <PMID Version="1">22955853</PMID>            </CommentsCorrections>            <CommentsCorrections RefType="Cites">                <RefSource>BMC Urol. 2009 Jun 24;9:6</RefSource>                <PMID Version="1">19552816</PMID>            </CommentsCorrections>            <CommentsCorrections RefType="Cites">                <RefSource>Nat Methods. 2015 Jul;12(7):685-91</RefSource>                <PMID Version="1">25984697</PMID>            </CommentsCorrections>            <CommentsCorrections RefType="Cites">                <RefSource>Int Urol Nephrol. 2005;37(3):439-45</RefSource>                <PMID Version="1">16307314</PMID>            </CommentsCorrections>            <CommentsCorrections RefType="Cites">                <RefSource>Lab Chip. 2016 Nov 29;16(24):4759-4769</RefSource>                <PMID Version="1">27858042</PMID>            </CommentsCorrections>            <CommentsCorrections RefType="Cites">                <RefSource>J Clin Oncol. 2005 Nov 1;23(31):7889-96</RefSource>                <PMID Version="1">16204015</PMID>            </CommentsCorrections>            <CommentsCorrections RefType="Cites">                <RefSource>BMC Cancer. 2012 May 16;12:178</RefSource>                <PMID Version="1">22591372</PMID>            </CommentsCorrections>            <CommentsCorrections RefType="Cites">                <RefSource>Lancet. 2010 Feb 20;375(9715):641-8</RefSource>                <PMID Version="1">20153039</PMID>            </CommentsCorrections>            <CommentsCorrections RefType="Cites">                <RefSource>Biosens Bioelectron. 2015 Sep 15;71:380-386</RefSource>                <PMID Version="1">25950932</PMID>            </CommentsCorrections>            <CommentsCorrections RefType="Cites">                <RefSource>Ther Adv Med Oncol. 2009 Jul;1(1):15-27</RefSource>                <PMID Version="1">21789110</PMID>            </CommentsCorrections>            <CommentsCorrections RefType="Cites">                <RefSource>Nature. 2013 Jul 4;499(7456):43-9</RefSource>                <PMID Version="1">23792563</PMID>            </CommentsCorrections>            <CommentsCorrections RefType="Cites">                <RefSource>Sci Rep. 2015 Jul 30;5:12642</RefSource>                <PMID Version="1">26223322</PMID>            </CommentsCorrections>            <CommentsCorrections RefType="Cites">                <RefSource>Genome Biol. 2017 May 8;18(1):84</RefSource>                <PMID Version="1">28482897</PMID>            </CommentsCorrections>            <CommentsCorrections RefType="Cites">                <RefSource>World J Urol. 2005 Jul;23(3):202-12</RefSource>                <PMID Version="1">15812574</PMID>            </CommentsCorrections>            <CommentsCorrections RefType="Cites">                <RefSource>J Cell Physiol. 2006 Mar;206(3):624-35</RefSource>                <PMID Version="1">16206250</PMID>            </CommentsCorrections>            <CommentsCorrections RefType="Cites">                <RefSource>Anticancer Res. 2011 Dec;31(12):4219-21</RefSource>                <PMID Version="1">22199284</PMID>            </CommentsCorrections>            <CommentsCorrections RefType="Cites">                <RefSource>Nature. 2007 Dec 20;450(7173):1235-9</RefSource>                <PMID Version="1">18097410</PMID>            </CommentsCorrections>            <CommentsCorrections RefType="Cites">                <RefSource>Mol Carcinog. 2009 Jul;48(7):633-41</RefSource>                <PMID Version="1">19072763</PMID>            </CommentsCorrections>            <CommentsCorrections RefType="Cites">                <RefSource>Sci Rep. 2015 Aug 19;5:13157</RefSource>                <PMID Version="1">26287771</PMID>            </CommentsCorrections>            <CommentsCorrections RefType="Cites">                <RefSource>Arch Pathol Lab Med. 2012 Feb;136(2):163-71</RefSource>                <PMID Version="1">22288963</PMID>            </CommentsCorrections>            <CommentsCorrections RefType="Cites">                <RefSource>Proc Natl Acad Sci U S A. 2015 Feb 17;112(7):E607-15</RefSource>                <PMID Version="1">25646488</PMID>            </CommentsCorrections>            <CommentsCorrections RefType="Cites">                <RefSource>Int J Mol Sci. 2016 Dec 20;17(12):</RefSource>                <PMID Version="1">27999407</PMID>            </CommentsCorrections>            <CommentsCorrections RefType="Cites">                <RefSource>PLoS One. 2013 Jun 28;8(6):e67466</RefSource>                <PMID Version="1">23840710</PMID>            </CommentsCorrections>            <CommentsCorrections RefType="Cites">                <RefSource>Nat Rev Urol. 2010 May;7(5):245-57</RefSource>                <PMID Version="1">20448658</PMID>            </CommentsCorrections>            <CommentsCorrections RefType="Cites">                <RefSource>Cancer Treat Rev. 2008 May;34(3):193-205</RefSource>                <PMID Version="1">18313224</PMID>            </CommentsCorrections>            <CommentsCorrections RefType="Cites">                <RefSource>Sci Rep. 2017 Jan 18;7:40766</RefSource>                <PMID Version="1">28098202</PMID>            </CommentsCorrections>            <CommentsCorrections RefType="Cites">                <RefSource>CA Cancer J Clin. 2011 Mar-Apr;61(2):69-90</RefSource>                <PMID Version="1">21296855</PMID>            </CommentsCorrections>            <CommentsCorrections RefType="Cites">                <RefSource>Cancer Epidemiol Biomarkers Prev. 2009 Aug;18(8):2190-4</RefSource>                <PMID Version="1">19661076</PMID>            </CommentsCorrections>            <CommentsCorrections RefType="Cites">                <RefSource>Nat Protoc. 2016 Jan;11(1):134-48</RefSource>                <PMID Version="1">26678083</PMID>            </CommentsCorrections>            <CommentsCorrections RefType="Cites">                <RefSource>Urol Oncol. 2017 Aug;35(8):507-515</RefSource>                <PMID Version="1">28551412</PMID>            </CommentsCorrections>            <CommentsCorrections RefType="Cites">                <RefSource>Biomed Microdevices. 2015 Apr;17(2):45</RefSource>                <PMID Version="1">25790944</PMID>            </CommentsCorrections>            <CommentsCorrections RefType="Cites">                <RefSource>Lab Chip. 2011 Jan 7;11(1):93-9</RefSource>                <PMID Version="1">20957273</PMID>            </CommentsCorrections>            <CommentsCorrections RefType="Cites">                <RefSource>Am J Pathol. 2000 Jan;156(1):57-63</RefSource>                <PMID Version="1">10623654</PMID>            </CommentsCorrections>            <CommentsCorrections RefType="Cites">                <RefSource>J Clin Oncol. 2014 Jun 20;32(18):1968-76</RefSource>                <PMID Version="1">24821879</PMID>            </CommentsCorrections>        </CommentsCorrectionsList>    </MedlineCitation>    <PubmedData>        <History>            <PubMedPubDate PubStatus="received">                <Year>2018</Year>                <Month>05</Month>                <Day>30</Day>            </PubMedPubDate>            <PubMedPubDate PubStatus="accepted">                <Year>2018</Year>                <Month>09</Month>                <Day>24</Day>            </PubMedPubDate>            <PubMedPubDate PubStatus="entrez">                <Year>2018</Year>                <Month>10</Month>                <Day>14</Day>                <Hour>6</Hour>                <Minute>0</Minute>            </PubMedPubDate>            <PubMedPubDate PubStatus="pubmed">                <Year>2018</Year>                <Month>10</Month>                <Day>14</Day>                <Hour>6</Hour>                <Minute>0</Minute>            </PubMedPubDate>            <PubMedPubDate PubStatus="medline">                <Year>2018</Year>                <Month>10</Month>                <Day>14</Day>                <Hour>6</Hour>                <Minute>0</Minute>            </PubMedPubDate>        </History>        <PublicationStatus>epublish</PublicationStatus>        <ArticleIdList>            <ArticleId IdType="pubmed">30315187</ArticleId>            <ArticleId IdType="doi">10.1038/s41598-018-33464-1</ArticleId>            <ArticleId IdType="pii">10.1038/s41598-018-33464-1</ArticleId>            <ArticleId IdType="pmc">PMC6185971</ArticleId>        </ArticleIdList>    </PubmedData></PubmedArticle></PubmedArticleSet>